J B Chemicals and Pharmaceuticals Limited has announced a key leadership change with the resignation of its Chief Financial Officer, Mr. Narayan Saraf, effective January 30, 2026. The announcement was made through a regulatory filing under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

Mr. Narayan Saraf, who serves as both Chief Financial Officer and Key Managerial Personnel of the company, tendered his resignation on January 28, 2026. The company has stated that the resignation is due to personal reasons and his desire to pursue other professional opportunities.

Regulatory Compliance

The disclosure was made in compliance with SEBI regulations, specifically referencing the SEBI Master Circular bearing reference number SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The company has explicitly stated that there are no other material reasons for the resignation beyond those mentioned in the official communication.

Company Information

J.B. Chemicals & Pharmaceuticals Limited operates from its registered office at Neelam Centre, Worli, Mumbai, and maintains its corporate office at Energy IT Park, Prabhadevi, Mumbai. The company trades on BSE under scrip code 506943 with the stock symbol JBCHEPHARM. The pharmaceutical company's corporate identity number is L24390MH1976PLC019380, indicating its incorporation in Maharashtra in 1976.

The resignation represents a significant change in the company's key management personnel, with the CFO position becoming vacant effective January 30, 2026. The company has fulfilled its regulatory obligations by promptly disclosing this material information to the stock exchanges and stakeholders.

J b chemicals and pharmaceuticals Limited has issued a corrigendum to rectify a date error in its board meeting outcome regarding a promoter reclassification request. The pharmaceutical company filed the correction on January 21, 2026, addressing an inadvertent mistake in the original board meeting disclosure.

Correction Details

The corrigendum specifically addresses serial number 4 of the board meeting outcome filed earlier on January 21, 2026. The company clarified that Tau Investment Holdings Pte. Ltd's request letter for reclassification was incorrectly dated as October 21, 2026, when the actual date was January 21, 2026.

Regulatory Framework

Tau Investment Holdings Pte. Ltd has requested reclassification from 'Promoter' to 'Public' category in accordance with Regulation 31A(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The entity has confirmed compliance with all applicable requirements under the specified regulation.

Filing and Compliance

The company has taken the following actions to ensure proper disclosure:

• Filed the corrigendum with BSE Limited on January 21, 2026
• Submitted the corrected request letter dated January 21, 2026 to stock exchanges
• Provided clarification through proper regulatory channels

The corrigendum was signed by Sandeep Phadnis, Vice President – Secretarial & Company Secretary, ensuring compliance with corporate governance requirements. The company has requested the stock exchange to take the correction on record for maintaining accurate regulatory filings.